
Keywords: IPF; idiopathic pulmonary fibrosis; AT1; angiotensin type 1 receptor; TGF; Transforming growth factor; BALF; bronchoalveolar lavage fluid; PPARs; peroxisome proliferator activated receptors; ARBs; angiotensin receptor blockers; CCR2b; chemokine C-C moti